The epidermal growth factor receptor (EGFR), also known as ErbB1 or HER1, together with three related receptors, ErbB2/HER2, ErbB3/HER3, and ErbB4/ HER4, constitute a subgroup of the receptor tyrosine kinase family of cell surface receptors. Receptors of the EGFR subgroup are critical components of signaling pathways that govern cell growth and differentiation during embryogenesis and adult homeostasis (Schlessinger, 2002) . Hyperactivity of these receptors, either by mutation or overexpression of ligand or receptor, contributes to a variety of human cancers (Sergina and Moasser, 2007) . Findings by Jura et al. (2009) and Brewer et al. (2009) provide new insights into the EGFR activation process, highlighting the role of the juxtamembrane region, the cytoplasmic segment of the receptor that connects the transmembrane helix to the tyrosine kinase domain.
In the "classical" scenario for receptor tyrosine kinase activation, a homodimeric ligand binds symmetrically to the ectodomains of two receptors, juxtaposing the cytoplasmic kinase domains for autophosphorylation (in trans) on tyrosine residues, which stimulates catalytic activity and creates docking sites for signaling proteins (Schlessinger, 2000) .
Although EGFR was the first receptor tyrosine kinase to be discovered (Carpenter et al., 1978) , its activation mechanisms have proven to be "nonclassical" at nearly every step. Unlike the dimeric ligands for other receptor tyrosine kinases, EGF is monomeric and forms a 1:1 complex with the EGFR ectodomain. Receptor dimerization is enabled through a conformational change in the ectodomain induced by ligand binding (Burgess et al., 2003) (Figure 1 ).
The mechanism of EGFR kinase activation in the ligand-stabilized receptor dimer also differs from the canonical mechanism, in which the two juxtaposed The activation process for the epidermal growth factor receptor (EGFR) involves formation of an asymmetric dimer of the tyrosine kinase domains. Jura et al. (2009) Stevan R. Hubbard * kinase domains autophosphorylate specific tyrosine residues in the kinase activation loop, the juxtamembrane region, and the region C-terminal to the kinase domain. Because of the divergent spatial positions of these sites, it is unlikely that the kinase domains form a stable dimer during the autophosphorylation process; some form of kinase "gymnastics" would seem to be required, a job better suited to monomeric kinase domains. In contrast to most receptor tyrosine kinases, EGFR is not activated by autophosphorylation of the activation loop. In fact, all of the tyrosine autophosphorylation sites reside in its extensive C-terminal tail, which would presumably not require the same degree of autophosphorylation "gymnastics." Instead, the EGFR kinase domains form a (relatively) stable homodimer, resembling the heterodimer formed between cyclin-dependent kinase-2 (CDK2) and its protein activator, cyclin A (Zhang et al., 2006) . In this asymmetric homodimer, one EGFR kinase domain plays the role of cyclin A (the activator/donor), and the other kinase domain plays the role of CDK2 (the receiver/acceptor) ( Figure 1 ). Only the receiver kinase domain is imbued with catalytic activity, and proceeds to phosphorylate tyrosine residues in the C-terminal tail of the receptor (whether in cis or trans, or both, is not known).
These findings set the stage for the current act in the EGFR activation drama: enter the juxtamembrane region. The juxtamembrane region in several receptor tyrosine kinases (such as Kit and the ephrin receptors) functions as an autoinhibitory segment, which is relieved through tyrosine phosphorylation therein (Hubbard, 2004) . As the new reports by Jura et al. (2009) and Brewer et al. (2009) demonstrate, the juxtamembrane region of EGFR is neither autoinhibitory nor neutral, but acts in an essential positive manner to stabilize formation of the asymmetric kinase dimer-yet another departure from the standard script.
As a structural starting point for their investigations, Jura et al. (2009) use the available crystal structure of the HER4 kinase domain, in which much of the juxtamembrane region is present in the construct and ordered in the structure. Brewer et al. (2009) crystallize their own EGFR cytoplasmic protein containing the full juxtamembrane region. In both cases, the structures show the now readily recognized asymmetric kinase dimer, with the C-terminal lobe of the activator kinase abutting the N-terminal lobe of the receiver kinase. The bonus feature in these structures is the behavior of the juxtamembrane region of the receiver kinase, which wraps around the C-terminal lobe of the activator kinase (Figure 1 ). Mutagenesis on both sides of the interface provides compelling evidence that this juxtamembrane segment (designated JM-B or JMAD) indeed stabilizes the activated dimer via the interactions viewed in the crystal structures. An EGFR-activating mutation found in non-small cell lung cancers (valine 665 to methionine) can now be rationalized from these structural findings (Brewer et al., 2009) .
JM-B/JMAD comprises residues 664-682, with the kinase domain beginning immediately thereafter. What about the membrane-proximal segment of the juxtamembrane region, residues 645-663, designated JM-A? The first nine residues (645-653) are nearly all basic, and these are followed by an EGFR family-conserved sequence: LRRLL (leucine or another hydrophobic residue). Jura et al. (2009) posit that this motif is helical and forms an antiparallel dimer with JM-A in the other EGFR molecule (within the EGF-stabilized dimer), for the purpose of facilitating formation of the asymmetric kinase dimer. As evidence, deletion of JM-A from either the receiver or activator molecule (using an elegant complementation strategy) results in a marked impairment of kinase activity in vitro (Jura et al., 2009 ). Moreover, their measurements using nuclear magnetic resonance on a peptide encompassing this region confirm the potential for JM-A to form an antiparallel helical dimer.
Intriguingly, the new crystal structure of the EGFR cytoplasmic domain reported by Brewer et al. (2009) , unlike the HER4 structure analyzed by Jura et al. (2009) (which lacks JM-A in the construct), contains a mostly ordered JM-A, and indeed the LRRLL motif is helical. Conspicuously absent, though, is a helical dimer; the JM-A helix points away from the C-terminal lobe of the activator kinase and makes lattice contacts that likely have no functional significance. The crystal structure of Brewer et al. (2009) would thus seem to cast some doubt on the JM-A helical-dimer hypothesis. However, it is certainly conceivable that, without the tethering of JM-A to the nearby transmembrane helix (lacking in the crystallized protein), the helical dimer is not sufficiently stable energetically to overcome the entropic costs. A model of the 2:2 complex of epidermal growth factor (EGF; orange) and its receptor (EGFR; individual molecules in the dimer are shown as magenta and cyan). Shown are the four subdomains (I-IV) of the EGFR ectodomain (see Burgess et al., 2003) and the transmembrane helices (rectangles; here, shown interacting). In the cytoplasm, the two tyrosine kinase domains form an asymmetric dimer, with the C-terminal lobe (C) of the activator/donor kinase (cyan) interacting with the N-terminal lobe (N) of the receiver/acceptor kinase (magenta), leading to activation of the latter (Zhang et al., 2006 ). In the model presented by Jura et al. (2009) , the juxtamembrane segment JM-A forms an antiparallel helical dimer to facilitate formation of the asymmetric kinase dimer. Jura et al. (2009) and Brewer et al. (2009) both suggest that the juxtamembrane segment JM-B/ JMAD of the receiver/acceptor kinase makes stabilizing contacts with the C-terminal lobe of the activator/donor kinase. The spatial disposition of JM-B/JMAD of the activator/donor kinase is unknown and not thought to be of functional consequence.
Finally, Jura et al. (2009) determine a crystal structure of an EGFR kinase domain (valine 924 to arginine) that is unable to form the activated kinase dimer, which reveals yet another potential regulatory mechanism for EGFR-in this case, inhibitory. In this new structure, a symmetric kinase dimer is observed in which the C-terminal tail of EGFR partially masks the site on its own C-terminal lobe to which the JM-B segment will bind (in trans) for activation. This inhibitory dimer could be the molecular basis for reports of preformed, nonsignaling EGFR dimers on the cell surface.
Other activation mechanisms involving JM-A have been proposed, including an electrostatic switch triggered by the binding of calmodulin (McLaughlin et al., 2005) . To add to the regulatory complexity, phosphorylation of threonine 654 in JM-A by protein kinase C is known to be inhibitory, but exactly how is still an open question. Furthermore, the model presented by Jura et al. (2009) for the EGF-triggered transition from the inactive kinase dimer (lacking a JM-A helical dimer) to the active kinase dimer (with a JM-A helical dimer) assumes that the EGFR transmembrane helices become closely apposed (Figure 1) , for which there is reasonable but not conclusive evidence. Thus, there are several issues regarding the EGFR signal-transduction mechanism that remain to be resolved.
By understanding all of the ins and outs of EGFR activation, there is hope that these mechanistic details can be exploited in the design of cancer therapeutics, either through targeting the ectodomain via antibodies or the kinase domain via small molecules. Indeed, recent advances in both therapeutic modalities provide reason for optimism (Sergina and Moasser, 2007) . Much as the tale of EGFR activation has unfolded scene by scene, we can be assured that each receptor tyrosine kinase will have its own story to tell.
During development, epithelial tissues are extensively remodeled while maintaining their polarized architecture. A well-studied example is dorsal closure in embryos of the fruit fly Drosophila. During dorsal closure the lateral ectoderm migrates as a sheet toward the dorsal midline (Figure 1 ). Cells at the leading edge accumulate high levels of actin and myosin II at their front, forming a supracellular actin cable that contracts to produce "purse-string" tension. Simultaneously, the underlying dorsal squamous epithelium called amnioserosa contracts and pulls the lateral ectoderm (Hutson et al., 2003) . Solon et al. (2009) now shed new light on how these two steps are coordinated. They show that pulsed contractile forces produced by amnioserosa cells are stabilized by epidermal actin cables to drive the movement of the epithelial sheet during dorsal closure in a ratchet-like mechanism.
Tissue remodeling relies on changes in cell shape as a result of forces generated by actomyosin cytoskeletal networks and the transmission of these forces at the cell cortex by adhesion molecules (Lecuit and Lenne, 2007 
